GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Float Percentage Of Total Shares Outstanding

Elanix Biotechnologies AG (FRA:ELN) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Elanix Biotechnologies AG's float shares is 0.00 Mil. Elanix Biotechnologies AG's total shares outstanding is 8.08 Mil. Elanix Biotechnologies AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Elanix Biotechnologies AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Elanix Biotechnologies AG's Institutional Ownership is 0.00%.

Elanix Biotechnologies AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Elanix Biotechnologies AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/8.08
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG (FRA:ELN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XSAT:ACUC XCNQ:VENI BOM:524202 CXUS ETST INNV BOM:524711 BOM:531726 CYIG ASX:AZT BOM:530233 SGX:BFK BUE:ROSE WAR:CBD XCNQ:RQB NSE:PAR BOM:540694 TSXV:GYSR OSTO:GABA XCNQ:GSTR
Traded in Other Exchanges
N/A
Address
Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474
Website
https://www.elanixbiotechnologies.ch
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines